NKGen Biotech (NKGNW) Stock Analysis
NASDAQHealthcareBiotechnology
What NKGen Biotech does
Established in 2021, Graf Acquisition Corp. IV is based in The Woodlands, Texas. This company currently conducts no major business operations; instead, its principal objective is to complete a strategic combination, such as a merger, acquisition of assets, stock exchange, or reorganization, with one or more existing businesses.
Key metrics
ETFs linked to NKGNW
Broad-market and Healthcare sector ETFs an investor holding NKGen Biotech is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how NKGNW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze NKGNW in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for NKGen Biotech?
- NKGen Biotech trades under the ticker NKGNW on NASDAQ.
- Which exchange is NKGNW listed on?
- NKGNW is listed on NASDAQ.
- What sector does NKGen Biotech operate in?
- NKGen Biotech is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze NKGNW in a portfolio?
- PortView shows NKGNW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.